These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 1537633)
1. Response of FR3T3 cells transformed by Ha-ras oncogene and epidermal growth factor gene to differentiation induction by N,N-dimethylformamide. Levine AE; Chakrabarty S Int J Cancer; 1992 Feb; 50(4):653-8. PubMed ID: 1537633 [TBL] [Abstract][Full Text] [Related]
2. Fibronectin/laminin and their receptors in aberrant growth control in FR3T3 cells transformed by Ha-ras oncogene and epidermal growth factor gene. Chakrabarty S; Jan Y; Levine A; McClenic B; Varani J Int J Cancer; 1989 Aug; 44(2):325-31. PubMed ID: 2527209 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145 [TBL] [Abstract][Full Text] [Related]
4. RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells. MartÃnez-Lacaci I; Kannan S; De Santis M; Bianco C; Kim N; Wallace-Jones B; Ebert AD; Wechselberger C; Salomon DS Int J Cancer; 2000 Oct; 88(1):44-52. PubMed ID: 10962438 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of transforming growth factor beta, N,N-dimethylformamide, and retinoic acid on transformed and nontransformed fibroblasts. Hoosein NM; Brattain DE; McKnight MK; Brattain MG Exp Cell Res; 1988 Mar; 175(1):125-35. PubMed ID: 3162213 [TBL] [Abstract][Full Text] [Related]
6. Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes. Game SM; Huelsen A; Patel V; Donnelly M; Yeudall WA; Stone A; Fusenig NE; Prime SS Int J Cancer; 1992 Sep; 52(3):461-70. PubMed ID: 1328069 [TBL] [Abstract][Full Text] [Related]
7. c-Ha-rasEJ transfection of rat aortic smooth muscle cells induces epidermal growth factor responsiveness and characteristics of a malignant phenotype. Sadhu DN; Lundberg MS; Burghardt RC; Ramos KS J Cell Physiol; 1994 Dec; 161(3):490-500. PubMed ID: 7962130 [TBL] [Abstract][Full Text] [Related]
8. Changes in receptor occupancy and growth factor responsiveness induced by treatment of a transformed mouse embryo cell line with N,N-dimethylformamide. Levine AE; McRae LJ; Brattain MG Cancer Res; 1985 Dec; 45(12 Pt 1):6401-5. PubMed ID: 2998599 [TBL] [Abstract][Full Text] [Related]
9. Modified responsiveness of v-Ha-ras-transfected rat fibroblasts to growth factors and a tumor promoter. Huang M; Kamata N; Nose K; Kuroki T Mol Carcinog; 1988; 1(2):109-15. PubMed ID: 3076452 [TBL] [Abstract][Full Text] [Related]
10. Regulation of heparin-binding EGF-like growth factor expression in Ha-ras transformed human mammary epithelial cells. MartÃnez-Lacaci I; De Santis M; Kannan S; Bianco C; Kim N; Wallace-Jones B; Wechselberger C; Ebert AD; Salomon DS J Cell Physiol; 2001 Feb; 186(2):233-42. PubMed ID: 11169460 [TBL] [Abstract][Full Text] [Related]
11. Cell surface features associated with differentiation-induction of methylcholanthrene-transformed AKR-2B fibroblasts by N,N-dimethylformamide. Marks ME; Ziober BL; Brattain MG Cancer Res; 1985 Mar; 45(3):1276-84. PubMed ID: 3855694 [TBL] [Abstract][Full Text] [Related]
12. Restoration of normal growth control and membrane antigen composition in malignant cells by N,N-dimethylformamide. Chakrabarty S; McRae LJ; Levine AE; Brattain MG Cancer Res; 1984 May; 44(5):2181-5. PubMed ID: 6608991 [TBL] [Abstract][Full Text] [Related]
13. Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. Normanno N; Selvam MP; Qi CF; Saeki T; Johnson G; Kim N; Ciardiello F; Shoyab M; Plowman G; Brandt R Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2790-4. PubMed ID: 7908443 [TBL] [Abstract][Full Text] [Related]
14. A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines. Chang MY; Won SJ; Liu HS J Cancer Res Clin Oncol; 1997; 123(2):91-9. PubMed ID: 9030247 [TBL] [Abstract][Full Text] [Related]
15. Regulation of surface-differentiation molecules by epidermal growth factor, transforming growth factor alpha, and hydrocortisone in human mammary epithelial cells transformed by an activated c-Ha-ras proto-oncogene. Basolo F; Serra C; Ciardiello F; Fiore L; Russo J; Campani D; Dolei A; Squartini F; Toniolo A Int J Cancer; 1992 Jun; 51(4):634-40. PubMed ID: 1601524 [TBL] [Abstract][Full Text] [Related]
16. Consequences of altered oncogene expression in rodent cells. Pragnell IB; Spandidos DA; Wilkie NM Proc R Soc Lond B Biol Sci; 1985 Oct; 226(1242):107-19. PubMed ID: 2866518 [TBL] [Abstract][Full Text] [Related]
17. N,N-dimethylformamide-induced synthesis of an anti-fibronectin reactive protein in cultured human colon carcinoma cells. Marks ME; Ziober BL; Brattain MG Cancer Res; 1986 Oct; 46(10):5248-58. PubMed ID: 3756877 [TBL] [Abstract][Full Text] [Related]